To ensure early diagnosis and intervention, international recommendations recommend that all patients with T1D undergo baseline and repeated thyroid function testing (TSH, free T4) and anti-TPO screening (Frommer And Kahaly 2021)
Most clinical protocols recommend 500 to 1000 IU administered one to three times weekly
for multi-entry laboratory handling
doi: 10.3389/fmed.2025.1535673 Received 27 November 2024 Accepted 25 March 2025 Published 04 April 2025 Volume 12 - 2025 Edited by Vasilios Kotsis, Aristotle University of Thessaloniki, Greece Reviewed by Panagiota Anyfanti, Aristotle University of Thessaloniki, Greece Raina D Ramnath, University of Bristol, United Kingdom Updates Copyright 2025 Wang, Zhang, Qu and Zhou
Hs01088679_g1) is reduced 24 5% by GHK-Cu, contributing to reduced de novo lipogenesis
If you reconstitute a vial and see clear solution, either the B12 was omitted or the concentration is extremely low